Target Name: KIFBP
NCBI ID: G26128
Review Report on KIFBP Target / Biomarker Content of Review Report on KIFBP Target / Biomarker
KIFBP
Other Name(s): kinesin family binding protein | KIF1BP | mutant KIF1 binding protein | DKFZP586B0923 | Kinesin family binding protein | KIF-binding protein | KIF1 binding protein | KBP | KIF1-binding protein | kinesin binding protein | KIAA1279 | TTC20 | KBP_HUMAN

KIFBP: A Potential Drug Target Or Biomarker

Kinesin Family Binding Protein (KIFBP) is a protein that plays a crucial role in the transport of various molecules across cell membranes. It is a member of the Kinesin family, which is known for its ability to transport proteins across the cell membrane in a process called transport. KIFBP is a protein that has been identified as a potential drug target or biomarker, and a great deal of research has been conducted on its properties and potential uses.

KIFBP is a protein that is expressed in most tissues of the body. It is primarily located in the cytoplasm, which is the fluid that surrounds the cells. KIFBP is involved in the transport of various molecules across the cell membrane, including proteins, nucleic acids, and small molecules. It is able to transport these molecules both inwards and outwards from the cell membrane, and it is thought to play a key role in the regulation of cell signaling and metabolism.

One of the reasons why KIFBP is considered a potential drug target is because it is involved in the regulation of a variety of cellular processes. For example, KIFBP has been shown to be involved in the regulation of cell proliferation, cell migration, and cell adhesion. It is also thought to play a role in the regulation of the cytoskeleton, which is the structure that gives cells shape and stability.

In addition to its role in cellular signaling, KIFBP is also of interest as a potential biomarker. The cytoplasm is a clear indicator of the health and function of a cell, and it is often used as a sample for various cellular assays. By studying the properties of the cytoplasm, researchers can gain insights into the health and function of cells.

One of the key advantages of KIFBP as a potential drug target is its relatively simple structure. KIFBP is a protein that is composed of a single polypeptide chain, which makes it relatively easy to study. This has allowed researchers to study its properties and behavior in great detail, and has provided a great deal of insight into its role in cellular signaling.

Another advantage of KIFBP is its ability to be modified. KIFBP can be modified by the addition of various side chains, which can alter its properties and behavior. This allows researchers to study the effects of these modifications on the function of KIFBP, and to use it as a tool for the development of new drug treatments.

In conclusion, KIFBP is a protein that has been identified as a potential drug target or biomarker. Its relatively simple structure and ability to be modified make it an attractive candidate for study, and its involvement in cellular signaling makes it a valuable tool for the development of new therapies. Further research is needed to fully understand the properties and behavior of KIFBP, and to determine its potential as a drug target or biomarker.

Protein Name: Kinesin Family Binding Protein

Functions: Required for organization of axonal microtubules, and axonal outgrowth and maintenance during peripheral and central nervous system development

The "KIFBP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KIFBP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KIFC1 | KIFC2 | KIFC3 | Killer Cell Immunoglobulin-Like Receptor (KIR) | Killer cell immunoglobulin-like receptor 2DS1, transcript variant X1 | KIN | Kinesin-like protein KIF16B (isoform 1) | KIR2DL1 | KIR2DL2 | KIR2DL3 | KIR2DL4 | KIR2DL5A | KIR2DL5B | KIR2DP1 | KIR2DS1 | KIR2DS2 | KIR2DS3 | KIR2DS4 | KIR2DS5 | KIR3DL1 | KIR3DL2 | KIR3DL3 | KIR3DP1 | KIR3DS1 | KIR3DX1 | KIRREL1 | KIRREL1-IT1 | KIRREL2 | KIRREL3 | KIRREL3-AS2 | KIRREL3-AS3 | KISS1 | KISS1R | KIT | KITLG | KIZ | KIZ-AS1 | KL | KLB | KLC1 | KLC2 | KLC3 | KLC4 | KLF1 | KLF10 | KLF11 | KLF12 | KLF13 | KLF14 | KLF15 | KLF16 | KLF17 | KLF17P1 | KLF2 | KLF3 | KLF3-AS1 | KLF4 | KLF5 | KLF6 | KLF7 | KLF8 | KLF9 | KLHDC1 | KLHDC10 | KLHDC2 | KLHDC3 | KLHDC4 | KLHDC7A | KLHDC7B | KLHDC7B-DT | KLHDC8A | KLHDC8B | KLHDC9 | KLHL1 | KLHL10 | KLHL11 | KLHL12 | KLHL13 | KLHL14 | KLHL15 | KLHL17 | KLHL18 | KLHL2 | KLHL20 | KLHL21 | KLHL22 | KLHL23 | KLHL24 | KLHL25 | KLHL26 | KLHL28 | KLHL29 | KLHL3 | KLHL30 | KLHL30-AS1 | KLHL31 | KLHL32 | KLHL33 | KLHL34 | KLHL35